Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.90 | N/A |
| PEG Ratio (TTM) | -0.04 | N/A |
| P/S Ratio (TTM) | 0.12 | N/A |
| P/B Ratio (TTM) | 0.35 | N/A |
| P/FCF Ratio (TTM) | 3.30 | N/A |
| Price to 5YR AVG Earnings Ratio | 5.59 | N/A |
| Price to 5YR AVG FCF Ratio | 1.04 | N/A |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.34% | N/A |
| ROE (TTM) | -32.02% | N/A |
| Net Profit Margin (TTM) | -17.74% | N/A |
| ROIC 5YR AVG | 9.20% | N/A |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -112.53% | 20.69% | -5.63% |
| Revenue | -1.14% | 0.98% | 2.26% |
| Net Income | -106.85% | 47.39% | 8.30% |
| Cash Flow | 351.31% | 17.08% | 6.26% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.91 | N/A |
| Quick Ratio (TTM) | 2.91 | N/A |
| D/E Ratio (TTM) | 2.90 | N/A |
| Interest Coverage (TTM) | -1.15 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 14.12 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.00% | N/A |